Committed to Fighting Cancer: 30+ Years of Carboplatin at Heraeus

In this article, we explain how Heraeus Precoius Metals business line Pharmaceutical Ingredients is committed to playing its part in increasing access to life-saving oncology medications.

For decades, platinum-based HPAPIs have changed the lives of patients for the better. In 2023, Heraeus Precious Metals delivered Carboplatin sufficient for approximately 2.3 million cycles of chemotherapy. This equates to an average of over 450,000 patients being treated. These figures are impressive. At the same time, however, the demand for Carboplatin is expected to increase even further. The Pharmaceutical Ingredients team at Heraeus is continuously monitoring the growing global demand for platinum HPAPIs and adjusting its capacity to supply ingredients for additional doses. In 2021, the company significantly expanded its platinum HPAPI production in Hanau with a multi-million euro investment. The increased capacity enables Heraeus to continue to respond promptly to high market demand in the future.